ENERGY-CHARGE AS AN INDICATION OF LIVER VIABILITY - A COMPARISON OF CHANGES IN LIVERS THAT REMAINED INTACT WITH THOSE SUBJECTED TO AUTOGRAFTING

被引:38
作者
HICKMAN, R [1 ]
ROSEINNES, C [1 ]
TYLER, M [1 ]
BRACHER, M [1 ]
LOTZ, Z [1 ]
FOURIE, J [1 ]
机构
[1] UNIV CAPE TOWN,MRC,CTR LIVER,CAPE TOWN,SOUTH AFRICA
关键词
D O I
10.1097/00007890-199203000-00009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
As efforts to assess the viability of liver grafts continue, the recent description of noninvasive measurement by fluorimetry or magnetic resonance spectrometry of adenine nucleotides has brought energy charge into focus again as an index of viability. Many previous studies have been conducted in human donor livers that have clinical relevance but which cannot be standardized, or in rats in which the hepatic artery is not anastomosed. In the present study, pig livers were definitively rendered ischemic for 1 or 2 hr. In one group the livers were then revascularized (intact) while in the other, the livers were removed during the final 20-30 min of the ischemic period and were subjected to autograft. There was a marked difference in survival between the intact and the autograft groups. One hour of ischemia in the intact group was associated with survival comparable to that of autograft controls (8-100 days); 2 hr of ischemia caused shortened survival, ranging from 2 to 18 days. In the recipients of autografts, survival after 1 hr of ischemia ranged from 3 to 16 days; after 2 hr of ischemia no autograft recipient survived overnight. The energy charge returned to the preoperative level after 2 hr of ischemia in both intact and autograft groups. The concentrations remained depressed after 2 hr of ischemia in autografted animals, thus being associated with survival. However, the patterns of total adenine nucleotide and adenosine triphosphate were not always similar to those of energy charge. The concentrations of aspartate aminotransferase were similarly elevated in all ischemic groups irrespective of duration or subsequent survival. There was, however, a close association between euglobulin lysis times (ELT) and survival. In the autograft recipients of livers subjected to 2 hr of ischemia that did not survive overnight the ELT remained significantly shortened. It is concluded that adenine nucleotide metabolism is important as an index of viability, but that concentrations of total and individual adenine nucleotides and the energy change all need to be computed. There does, however, appear to be an absolute relationship between survival and euglobulin lysis time that would be clinically useful in patients undergoing liver transplantation or hepatic vascular exclusion.
引用
收藏
页码:540 / 545
页数:6
相关论文
共 26 条
[11]  
JAWOREK D, 1974, METHOD ENZYMAT AN, V4, P2078
[12]   FOR HOW LONG CAN THE LIVER TOLERATE ISCHEMIA [J].
KAHN, D ;
HICKMAN, R ;
DENT, DM ;
TERBLANCHE, J .
EUROPEAN SURGICAL RESEARCH, 1986, 18 (05) :277-282
[13]   ORTHOTOPIC LIVER-TRANSPLANTATION IN THE RAT - TECHNIQUE USING CUFF FOR PORTAL-VEIN ANASTOMOSIS AND BILIARY DRAINAGE [J].
KAMADA, N ;
CALNE, RY .
TRANSPLANTATION, 1979, 28 (01) :47-50
[14]   ADENINE-NUCLEOTIDE METABOLISM AND ITS RELATION TO ORGAN VIABILITY IN HUMAN-LIVER TRANSPLANTATION [J].
KAMIIKE, W ;
BURDELSKI, M ;
STEINHOFF, G ;
RINGE, B ;
LAUCHART, W ;
PICHLMAYR, R .
TRANSPLANTATION, 1988, 45 (01) :138-143
[15]   60 MINUTES OF NORMOTHERMIC ISCHEMIA IN THE RAT-LIVER - CORRELATION BETWEEN ADENINE-NUCLEOTIDES AND BILE EXCRETION [J].
KARWINSKI, W ;
HUSOY, AM ;
FARSTAD, M ;
SOREIDE, O .
JOURNAL OF SURGICAL RESEARCH, 1989, 46 (02) :99-103
[16]   HEPATIC TRANSPLANTATION SURVIVAL - CORRELATION WITH ADENINE-NUCLEOTIDE LEVEL IN DONOR LIVER [J].
LANIR, A ;
JENKINS, RL ;
CALDWELL, C ;
LEE, RGL ;
KHETTRY, U ;
CLOUSE, ME .
HEPATOLOGY, 1988, 8 (03) :471-475
[17]  
LEMPINEN M, 1973, SURGERY, V73, P463
[18]   LEVELS OF PURINE COMPOUNDS IN A PERFUSATE AS A BIOCHEMICAL MARKER OF ISCHEMIC-INJURY OF COLD-PRESERVED LIVER [J].
NISHIDA, T ;
KOSEKI, M ;
KAMIIKE, W ;
NAKAHARA, M ;
NAKAO, K ;
KAWASHIMA, Y ;
HASHIMOTO, T ;
TAGAWA, K .
TRANSPLANTATION, 1987, 44 (01) :16-21
[19]  
NORDLINGER B, 1980, SURG GYNECOL OBSTET, V150, P859
[20]  
OKAMOTO R, 1988, TRANSPLANT P, V20, P969